• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Confidentiality Concerns Raised by DNA-Based Tests in the Market-Driven Managed Care Setting (Final Report)
【24h】

Confidentiality Concerns Raised by DNA-Based Tests in the Market-Driven Managed Care Setting (Final Report)

机译：市场驱动的管理式护理环境中基于DNa的测试引发的保密问题（最终报告）

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In a policy climate where incentives to cherry pick are minimized, Managed Care Organizations can implement practices that safeguard medical privacy to the extent that data is protected from falling into the hands of third parties who could misuse it to discriminate. To the extent that these practices have been codified into the regulatory framework of the Health Insurance Portability and Accountability Act (HIPAA) consumers may be able to rest easy about their genetic data being revealed to third parties who may discriminate. However, there are limitations to the use of policy instruments to prevent the discrimination of an entire genre of clients by market driven managed care organizations. Policy measures, to assure that knowledge of genetic conditions and their future costs would not be used by market driven managed care organizations to implement institutional policies and products that would implicitly discriminate against a genre of clients with genetic conditions, present difficulties.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号